Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Corvas and Schering-Plough extend HCV agreement

May 17, 1999

Clinical trials of OP-2000 for IBD to begin later this year

May 14, 1999

European Union approval obtained for Schering-Plough's combination HCV therapy

May 13, 1999

Axcan and Vianex sign letter of intent related to H. pylori treatment

May 12, 1999

HCV antisense oligonucleotide reduces HCV gene expression in mouse model

May 10, 1999

Potent, orally active antiulcer agents synthesized at SS Pharm.

May 10, 1999

Infliximab promotes healing of fistulas in patients with Crohn's disease

May 6, 1999

New antiulcer drug expected to reach Spanish market later this year

May 4, 1999

Health Canada expands approved uses of Rebetron

May 3, 1999

Pivotal results demonstrate equal efficacy and better tolerability of Diacol versus NuLYTELY

May 3, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...